Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis (MASH) for $4.7 billion upfront, shortly after claiming FDA approval to ...

Screenshot of PathAI's AIM-MASH AI Assist in action. An artificial intelligence model developed by PathAI – used to help diagnose metabolic dysfunction associated steatohepatitis (MASH) from liver ...

A settlement is reached in the case of Mike Disfarmer, who renounced his family. Decades later they sued to take back his life’s work. When heirs battle the people who built their legacies, the art ...

We help a reader find a prop seen in Durga Chew-Bose’s debut film “Bonjour Tristesse.” By Tom Delavan A couple transformed their apartment into a refuge that doubles as an ever-evolving showroom. By ...